New FDA Guidance for Remdesivir Use in COVID-19 Patients
The FDA says co-administration of remdesivir and chloroquine phosphate or hydroxychloroquine sulfate is not recommended as it may result in reduced antiviral activity of remdesivir.
Tag: hydroxychloroquine
New FDA Guidance for Remdesivir Use in COVID-19 Patients
The FDA says co-administration of remdesivir and chloroquine phosphate or hydroxychloroquine sulfate is not recommended as it may result in reduced antiviral activity of remdesivir.
Read More
Hydroxychloroquine, Chloroquine Lose FDA Emergency Use Authorization for COVID-19
The FDA has revoked its emergency use authorization for hydroxychloroquine and chloroquine for treatment of COVID-19 patients, according to a June 15 alert on the agency’s website.
Read MoreHydroxychloroquine: No Evidence of COVID-19 Prevention
According to a study to be published in the New England Journal of Medicine, researchers found no evidence that treatment with the malaria drug hydroxychloroquine prevented COVID-19 infection in those exposed to COVID-19 positive patients.
Read More